Skip to content
Breaking News

Breaking News

  • Home
  • World
  • Business
  • Health
  • Entertainment
  • Life Style
  • Sports
  • Toggle search form

Tag: Breaking News: Business

FTC sues drug middlemen for allegedly inflating insulin prices

Posted on September 21, 2024 By Admin No Comments on FTC sues drug middlemen for allegedly inflating insulin prices
FTC sues drug middlemen for allegedly inflating insulin prices

Lina Khan, Chair of the Federal Trade Commission (FTC), testifies before the House Appropriations Subcommittee at the Rayburn House Office Building on May 15, 2024 in Washington, DC.  Kevin Dietsch | Getty Images News | Getty Images The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the…

Read More “FTC sues drug middlemen for allegedly inflating insulin prices” »

Health

Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial

Posted on August 20, 2024 By Admin No Comments on Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial
Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial

Eli Lilly’s highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults with prediabetes compared with a placebo, according to initial results from a long-term study released Tuesday.  The late-stage trial on tirzepatide, the active ingredient in the company’s weight loss injection Zepbound and diabetes…

Read More “Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial” »

Health

Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says

Posted on August 2, 2024 By Admin No Comments on Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters All doses of Eli Lilly’s highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S., according to an update on the U.S. Food and Drug…

Read More “Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says” »

Health

In this fast-paced bull market, we’re increasing our Club price targets on 4 stocks

Posted on February 15, 2024 By Admin No Comments on In this fast-paced bull market, we’re increasing our Club price targets on 4 stocks
In this fast-paced bull market, we’re increasing our Club price targets on 4 stocks

It’s been hard to keep up. That’s the story of the big stock winners this year. They just keep winning and winning and winning. For analysts on Wall Street and here at the Club, it seems like some of these names are smashing through our six-to-nine-month price targets every few weeks. To that end, we’re…

Read More “In this fast-paced bull market, we’re increasing our Club price targets on 4 stocks” »

Health

FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition

Posted on September 1, 2023 By Admin No Comments on FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition
FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition

The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images The Federal Trade Commission on Friday said it has reached a deal with drug giant Amgen to allow the company’s $27.8 billion purchase of Horizon Therapeutics to move forward.  The two companies now expect…

Read More “FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition” »

Health

Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know

Posted on July 8, 2023 By Admin No Comments on Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know
Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know

The Alzheimer’s drug Leqembi is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai | via Reuters Medicare has agreed to pay for the Alzheimer’s treatment Leqembi, a major turning point for patients who are diagnosed with the early stages of the disease. Leqembi is the only drug on the…

Read More “Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know” »

Health

Posts pagination

Previous 1 2

Recent Posts

  • Pakistan to Bowl First Against Australia in ICC Women’s Cricket World Cup – SUCH TV
  • New Zealand’s Coastal Waters Heating Up Faster Than World Average – SUCH TV
  • Taylor Swift clarifies she didn’t talk about her engagement at Selena Gomez’s wedding
  • Mangoes More Effective Than Low-Sugar Snacks in Reducing Prediabetes Risk, Study Finds – SUCH TV
  • ICC urged to end ‘pre-arranged’ India-Pakistan clashes

Categories

  • Business
  • Entertainment
  • Health
  • Life Style
  • Sports
  • World

Copyright © 2025 Breaking News.

Powered by PressBook Blog WordPress theme